8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Oct 8, 2024 · 1y ago · Accession 0000950170-24-113520
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Cue Biopharma, Inc.
- Ticker
- CUE
- CIK
- 1645460
- Form type
- 8-K
- Filing date
- Oct 8, 2024
- Report date
- Oct 8, 2024
- Document
- cue-20241008.htm
- Size
- 215 KB